PDI (PDII) Awarded Sales Contract with Top Pharma Company; Expects $10M - $12M in Revs for FY10
Tweet Send to a Friend
PDI, Inc. (NASDAQ: PDII) has been awarded a new contract sales engagement with a Top 10 pharmaceutical company that is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
